Escalating conflict involving Iran is disrupting the global helium supply, raising concerns for healthcare operations that rely on the gas for imaging and surgical procedures.
About one-third of the global helium supply has been affected following damage to production facilities in Qatar and shipping disruptions through the Strait of Hormuz, according to a March 27 report from The New York Times. Roughly 200 specialized containers used to transport helium have also been stranded, further tightening supply.
Helium is essential for cooling superconducting magnets in MRI machines and is also used in certain surgical procedures, making it difficult to replace in clinical settings, according to an April 7 report from NBC News affiliate KSNW.
The disruption is expected to drive up costs and may take months to fully ripple through supply chains, as healthcare providers and other industries draw on existing inventories.
The shortage builds on years of instability in helium supply, which hospital leaders have flagged as a growing risk to imaging capacity. MRI machines require large volumes of liquid helium to operate, and there is no viable substitute, raising the risk of service disruptions during prolonged shortages.
Health systems and manufacturers have begun adapting to supply constraints. Some newer MRI systems use significantly less helium, and more than 1,000 low-helium scanners have been deployed globally. However, the technology is not yet widespread, and most systems remain dependent on steady helium access.
The helium shortage also has downstream implications for semiconductor manufacturing, where the gas is used in chip production, potentially affecting the availability of technology that supports AI and other healthcare systems, according to the Times.
The supply shock adds to broader pharmaceutical risks tied to the Iran conflict. Disruptions in the Strait of Hormuz and rising energy prices have raised concerns about generic drug availability and production costs, particularly as India — which supplies 47% of U.S. generics — relies on the region for shipping routes and petrochemical inputs. Analyses have also noted vulnerabilities in antibiotics, anesthetics and other essential medicines tied to regional production and global distribution patterns.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
